MedPath

Comparison With Open and Totally Laparoscopic Gastrectomy for Gastric Cancer

Completed
Conditions
Gastric Cancer
Registration Number
NCT04481828
Lead Sponsor
Kocaeli Derince Education and Research Hospital
Brief Summary

In gastric cancer, laparoscopic gastrectomy is commonly performed in Asian countries. In other regions where tumor incidence is relatively low and patient characteristics are different, developments in this issue have been limited. In this study, the investigators aimed to compare the early results for patients who underwent open or laparoscopic gastrectomy for gastric cancer in a center in Turkey.

Detailed Description

The patients who were operated in Kocaeli Derince Training and Research Hospital between January 2014 and January 2019 consecutively due to gastric cancer were analyzed. The diagnosis was made by upper gastrointestinal endoscopy and endoscopic biopsy. Clinical staging was done using contrast computed tomography (CT). Positron emission tomography (PET) was used in patients with suspected metastasis.The patients were divided into two groups according to the technique applied (open, laparotomy). The first group (Group 1; n: 30) consisted of patients who underwent open surgery, and the second group (Group 2, n: 30) laparoscopic surgery.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Gastric cancer(adenocarcinoma) proven biopsy
  • Operated by same surgical team
  • Presence of distant metastasis
Exclusion Criteria
  • Patients who underwent palliative resection
  • operated by a different surgical team
  • ASA score: 4

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Body mass index2014- 2019

kg/m2

Gender2014-2019

male or female

Surgical technique2014-2019

open or laparoscopic

Operation time2014 - 2019

minute

Complication (Clavien-Dindo Classification)2014 - 2019

1,2,3 A,3 B,4 A,4 B,5 (according to Clavien-Dindo Classification)

Age2014-2019

year

Tumor localization2014 - 2019

proximal, middle, lower

Gastrectomy type2014 - 2019

total, subtotal

Lymph node dissection type2014 - 2019

D1+, D2

Blood loss2014 - 2019

ml

30-day mortality2014 - 2019

present or absent

Number of harvested lymph node2014 - 2019

number

Resection margin status2014 - 2019

positive or negative

Tumor stage (American Joint Committee on Cancer 8th Edition)2014 - 2019

0,1,2 A,2 B,3,4 A, 4 B (According to American Joint Committee on Cancer 8th Edition)

Previous abdominal surgery status2014-2019

yes or no

Comorbidity status2014 -2019

present or absent

Neoadjuvant therapy status2014-2019

present or absent

American Society of Anesthesiologists (ASA) score2014-2019

1,2,3,4

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Kocaeli Derince Training and research Hospital

🇹🇷

Kocasinan, Derince, Turkey

Kocaeli Derince Training and research Hospital
🇹🇷Kocasinan, Derince, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.